PROCEPT BioRobotics Reports Third Quarter 2022 Financial Results and Increases 2022 Revenue Guidance

Go back to PROCEPT BioRobotics Reports Third Quarter 2022 Financial Results and Increases 2022 Revenue Guidance

PROCEPT BioRobotics Corporation (PRCT) Misses Q3 EPS by 1c

November 3, 2022 4:35 PM EDT

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) reported Q3 EPS of ($0.51), $0.01 worse than the analyst estimate of ($0.50). Revenue for the quarter came in at $20.3 million versus the consensus estimate of $16.79 million.

GUIDANCE:

PROCEPT BioRobotics Corporation sees FY2022 revenue of $72.5 million.

For earnings... More